Dr Spyros Retsas

Sentinel node biopsy confers no added protection to patients with melanoma

• Journal of the Royal Society of Medicine
• August 2007

• A “surgical” staging procedure in any cancer becomes essential when it provides unique information that influences the management of a particular cancer to the benefit and welfare of the patient. T...

Treatment at Random: The Ultimate Science or the Betrayal of Hippocrates?

• Journal of Clinical Oncology
• December 2004

can viruses cause melanoma?

• Melanoma Research
• August 2004

• Clinical observations on the behaviour of cutaneous melanoma are indicative of viral involvement in the induction and progression of this neoplasm

The origins, etymology and meaning of metastasis in the context of cancer.

• ESMO Open
• July 2017

• Metastasis, in Greek, means removal or migration, dislocation, but also departing from life. Plato and Aristotle used the term metastasis to discuss the change, by revolution or transition, of a po...

Geotherapeutics: the medicinal use of earths, minerals and metals from antiquity to the...

• Geological Society London Special Publications
• December 2016

• In antiquity, therapeutic empiricism attributed medicinal properties to animal products, plants, minerals and metals, including the soil of specific geographic locations. The therapeutic use of cer...

Ipilimumab and Vemurafenib in melanoma

• Journal of the Royal Society of Medicine
• June 2011

• This study evaluates early reports on two novel treatments and their impact on the management of metastatic melanoma : 1) Ipilimumab which targets the cytotoxic T-lymphocyte-associated antigen ...

Medical experiments in antiquity

• The Lancet
• August 2010

• Although the medical experiment is considered the product of the European Renaissance, Galen conducted and thoroughly described medical experiments, one of which is briefly described in this commun...

In Reply:

• Journal of Clinical Oncology
• July 2005

Prognostic factors of cutaneous melanoma and a new staging system proposed by the Ameri...

• European Journal of Cancer
• March 2002

Adjuvant therapy of malignant melanoma: is there a choice?

• Critical Reviews in Oncology/Hematology
• November 2001

Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma

• Cancer Immunology Immunotherapy
• January 2001

Melanoma and additional primary cancers

• Melanoma Research
• April 2000

Adjuvant therapy of melanoma

• The Lancet
• August 1998

Taxol and vinorelbine: a new active combination for disseminated malignant melanoma

• Anti-Cancer Drugs
• February 1996

Cutaneous Melanoma-associated Retinopathy

• Ophthalmology
• November 1994

Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adju...

• Cancer
• April 1994

Central nervous system lnvolvement in malignant melanoma

• Cancer
• May 1988

• Cerebral metastases from melanoma can respond to chemotherapy with or without combination with radiotherapy.

EARLY OR LOW-GRADE MELANOMA?

• The Lancet
• August 1987

Missed malignant melanoma

• BMJ
• July 1986

Missed malignant melanoma

• BMJ
• May 1986

Sun beds and melanoma.

• BMJ
• March 1983

Pigment streaks in the nail plate due to secondary malignant melanoma

• British Journal of Dermatology
• March 1983

Vindesine as a single agent in the treatment of advanced malignant melanoma

• Cancer Chemotherapy and Pharmacology
• January 1979

Insulin abuse by a drug addict.

• BMJ
• December 1972

Successful bone marrow transplant for Fanconi's anaemia.

• BMJ
• February 1977

Gods behaving badly

• Journal of Medical Biography
• October 2013

• The definition of Asclepiad Hippocrates and his alleged descent from the family line of Aesculapius

Alexander the Great and his interest in medicine

• Journal of Medical Biography
• August 2009

• The article addresses medical aspects of Alexander's Asian campaign, the multiple injuries that he sustained in battle and the role of eponymous physicians and military surgeons involved in the tre...

Adjuvant vindesine in metastatic melanoma

• Melanoma Research
• April 2009

• A critique of a randomised trial inadequately analysed for prognostic factors.